SCHEMBL3527334

SCHEMBL3527334

FC(F)c1ccccc1-c1ccnc(N2CCNCC2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.49
ACHE P22303 3/20 0.48
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HTR7 P34969 1/20 0.43
CCNT1 O60563 4/20 0.42
CCNA2 P20248 4/20 0.42
CDK2 P24941 4/20 0.42
CDK9 P50750 4/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
HTR2C P28335 1/20 0.41
DYRK1A Q13627 2/20 0.40
PLD1 Q13393 1/20 0.39
PIK3CD O00329 1/20 0.39
PIK3R1 P27986 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CB P42338 1/20 0.39
PIK3CG P48736 1/20 0.39
EIF2AK2 P19525 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13309353 0.83 ADRB1 (0.52) ADRB1ACHEKDM4EALDH1A1HTR7
Hydrochloric Acid SCHEMBL3273474 0.82 KDM4E (0.51) ADRB1ACHEKDM4EALDH1A1HTR7
SCHEMBL3534834 0.81 SMARCA2 (0.53) ADRB1ACHEKDM4EALDH1A1HTR7
SCHEMBL12469782 0.78 FAAH (0.54) ADRB1ACHEKDM4EALDH1A1HTR7
SCHEMBL26985639 0.77 HTR7 (0.56) ADRB1KDM4EALDH1A1HTR7CCNT1
SCHEMBL31505935 0.77 HTR7 (0.56) ADRB1KDM4EALDH1A1HTR7CCNT1
SCHEMBL3529715 0.77 CYP1A2 (0.66) ADRB1KDM4EALDH1A1HTR7CYP1A2
Hydrochloric Acid SCHEMBL3268535 0.77 FAAH (0.53) ADRB1ACHEKDM4EALDH1A1HTR7
SCHEMBL2225874 0.76 KMT2A (0.57) ADRB1ACHEKDM4EALDH1A1HTR7
Hydrochloric Acid SCHEMBL3272283 0.75 ALDH1A1 (0.57) ADRB1ACHEKDM4EALDH1A1HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7858786-B2 Pyrimidines and pyrazines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCOROPATED (US) 2010-12-28 US disclosed
US-20070093454-A1 Pyrimidines and pyrazines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED 2007-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093454-A1 Pyrimidines and pyrazines useful as modulators of ion channels KCNJ1, KCNJ2, KCNJ11 ADRB1 1646/4885ACHE 1100/4885KDM4E 2470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.